Xconomy -- Calypso Medical Technologies, on the surface, looked like it was on the brink of breakout success in September 2009. The Seattle-based company raised $50 million in venture capital—the biggest investment that year in Washington state—to beef up R&D, hire more people, and take its system for precision-guided cancer radiation treatment beyond the U.S. market and onto the world stage.
